|Bid||82.800 x 1000|
|Ask||82.810 x 800|
|Day's Range||82.31 - 83.90|
|52 Week Range||76.21 - 111.25|
|Beta (3Y Monthly)||0.04|
|PE Ratio (TTM)||19.25|
|Earnings Date||Feb 6, 2019 - Feb 11, 2019|
|Forward Dividend & Yield||4.56 (5.41%)|
|1y Target Est||94.31|
Will 2019 Be Better for Altria and Philip Morris? Of the 17 analysts that follow Altria Group (MO), 58.8% are favoring a “buy,” and 41.2% are favoring a “hold.” There aren’t any “sell” ratings on the stock. On December 7, Barclays initiated coverage on Altria with an “overweight” rating and a target price of $64.
Will 2019 Be Better for Altria and Philip Morris? Dividends help smooth out return volatility for shareholders. Both Philip Morris International (PM) and Altria Group (MO) have a strong history of returning cash to shareholders.
Analysts expect Philip Morris International’s (PM) revenue to rise by 2.7% to $29.54 billion in 2018. They expect the company’s revenue for 2019 to be at $30.33 billion, which represents YoY growth of 2.7% from 2018.
Will 2019 Be Better for Altria and Philip Morris? In the first three quarters of 2018, Altria Group (MO) posted adjusted EPS of $3.04, which represents growth of 22.6% from $2.48 in the corresponding three quarters of the previous year. Also, the company has outperformed analysts’ EPS expectations in all three quarters.
Will 2019 Be Better for Altria and Philip Morris? In the first three quarters of 2018, Philip Morris International (PM) posted net revenue growth of 8.2%, outperforming Altria Group’s (MO) net revenue growth of 0.4%. During the period, Philip Morris posted net revenue of $22.13 billion compared to $20.45 billion in the first three quarters of 2017.
Will 2019 Be Better for Altria and Philip Morris? 2018 has been tough for tobacco companies. The increased anti-tobacco regulations, the declining smoking population, and the rising competition in the RRP (reduced-risk products) space have been putting pressure on tobacco companies.
Yes, there was a strong rebound off the October lows, which is classic market action. Almost textbook as well is the dramatic intra-day swings and alternating days of declines and advances, explains dividend specialist and value investing expert, Kelley Wright, editor of IQ Trends.
NEW YORK, Dec. 10, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Concerns over rising interest rates and expected further rate increases have hit several stocks hard since the end of the third quarter. NASDAQ and Russell 2000 indices are already in correction territory. More importantly, Russell 2000 ETF (IWM) underperformed the larger S&P 500 ETF (SPY) by about 4 percentage points in the first half of […]
One of the world’s biggest tobacco companies is bullish on bud. Altria, parent company of New York-based Philip Morris (NYSE: PM) and maker of Marlboro cigarettes, invested $2.4 billion into a Toronto medical and recreational marijuana company.
Altria said has discontinued its MarkTen and Green Smoke e-cigarettes. Altria is considering a significant minority stake in Juul, a person familiar with the matter told CNBC. If the Food and Drug Administration clears Philip Morris International's heated tobacco product, iQOS, Altria will sell it in the U.S.